Prevention and cure effect of immunoregulation therapy on postoperative infectious complications of calculous obstructive jaundice
10.3760/cma.j.issn.1007-8118.2012.11.012
- VernacularTitle:免疫调理对结石性梗阻性黄疸术后感染并发症的防治作用
- Author:
Ren JI
;
Yong NI
;
Jing ZHANG
;
Haoyuan DENG
;
Minjie ZHANG
;
Qing HAN
;
Chengyou WANG
- Publication Type:Journal Article
- Keywords:
Cholestasis;
Immunotherapy;
Infection
- From:
Chinese Journal of Hepatobiliary Surgery
2012;(11):851-854
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the prevention and cure effect of immunoregulation therapy on postoperative infectious complications of calculous obstructive jaundice.Methods Prospective,randomized,blind and controlled clinical analysis of 40 patients conforming to the standard of calculous obstructive jaundice was carried out.The patients were divided into two groups at random.One was control group (n=20) with regular therapy,and the treatment group (n=20) with ulinastatin plus thymosin-α1 on the base of regular therapy for 1 week.The immunological indexes were determined before and after therapy on the 1st,3rd,5th、7th and 14th day,including the changes in lymphocyte count,CD14+ monocytes human leukocyte antigen (locus) DR (HLA-DR),and the incidence of postoperative infection were observed.Results The incidence of postoperative infectious complications in treatment group (10％) was remarkable lower than that in control group (30％,P＜0.01).There was significant difference between two groups (P＜0.05).After the 3rd,up to 14th day of therapy,the counts of lymphocyte and CD14+ monocytes HLA-DR were significantly higher than those in control group (all P＜0.05).Conclusions Immunoregulation therapy can improve the prognosis of obstructive jaundice patients in a period of 14 days of observation,and lymphocyte counts and CD14+monocytes HLA-DR were increased significantly,showing that immuno suppression can be ameliorated.Immunoregulation therapy could effectively prevent infectious complications of calculous obstructive jaundice.
